Inhalation Therapy Nebulizer Market

SKU: DMMD2898 | Last Updated On: Aug 04 2022 | Available Formats

> Global Inhalation Therapy Nebulizer Market Expected to reach a high CAGR during the forecast period 2022-2029: DataM Intelligence

Inhalation Therapy Nebulizer Market is segmented By Type (Mesh Nebulizer, Pneumatic Nebulizer, Ultrasonic Nebulizer, Jet nebulizers), By Applications (Asthma, COPD, Cystic fibrosis, Other), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Other), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029

Market Overview

The Global "Inhalation Therapy Nebulizer Market" is estimated to reach at a high CAGR 6.1% during the forecast period (2022-2029).   

Inhalation therapy nebulizer is a medical device that converts the drug into mist and delivers it directly to the lungs. The inhalation therapy nebulization technique is commonly used to treat respiratory diseases, including asthma, cystic fibrosis, and COPD. Various devices are used for nebulization. The devices that are rechargeable and electrically powered are most widely used.

Market Dynamics

The global inhalation therapy nebulizer market growth is driven by the growing incidence of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population base are among the key factors driving the market growth.

The increasing prevalence of chronic respiratory diseases is expected to drive growth in the forecast period.

The increasing prevalence of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population base drive the market growth. Nebulizers are respiratory drug delivery devices that transform liquid medications into aerosols (liquid particles in a gas). The drug is converted into a mist that can be directly delivered to the patient's lungs. The rising incidences of chronic respiratory diseases and rapid technological advances are among the key factors driving the usage of nebulizers. The adoption is also increasing, due to the demand for new technologies with higher quality, smaller size, lighter weight, and ease of accessibility, by the patients. Thus, the increasing demand for these devices is driving the market's growth.

Increased demand for home healthcare devices is expected to drive market growth.

Home healthcare devices have been gaining popularity and market share in recent years. Miniaturization of products and technological advancements boost home healthcare devices' adoption. Furthermore, rowing needs to curb healthcare expenditure is expected to be some of the high-impact rendering drivers for home healthcare devices. Home healthcare is a cost-effective alternative to expensive hospital stays, expected to boost the market. Easy availability of compact nebulizers that are ideal for home use and technological innovations in nebulizers to reduce the sound created by them and improve their functionality are increasing their adoption in-home healthcare. These factors are driving the growth of the market in the forecast period.

Side effects associated with drug inhalation are likely to hinder market growth.

However, complications and side-effects associated with drug inhalation, unavailability of a single effective inhaler device and lack of awareness are restraining the market.

COVID-19 Impact Analysis

Many of the patients use a home nebulizer to care for their respiratory conditions. A patient with COVID-19 or suspected COVID-19 must use a nebulizer at home. Moreover, the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, is working with regulatory authorities to get approval for a nebulizer-based inhalation therapy it has designed for use in COVID patients. The inhalation therapy for combating COVID-19 is very effective. These factors are driving the growth of the market in the forecast period.

Inhalation Therapy Nebulizer Market Scope

Metrics

Details

Market CAGR

6.1%

Segments Covered

 By Type,  By Form, By End User, By Distribution Channel, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

Segment Analysis

Mesh Nebulize segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

Mesh nebulizers have become the first choice for new nebulized pharmaceutical drug developments. Thus it was estimated that mesh nebulizers would be increasingly adopted in the coming future. This is due to their low residual volumes and accurate lung delivery due to the portability, convenience, and speed of treatment. Thus, technological advancements in mesh nebulizers, with the development of an innovative solution, are likely to further drive the market's growth in the future. An analysis of EU and US clinical trial databases has shown that mesh nebulizers are now preferred overjet nebulizers for clinical trials sponsored by pharmaceutical companies. The results show a strong preference for mesh nebulizers in trials involving high cost and niche therapy areas. Built-in capability to optimize the way patients use their mesh nebulizer and manage their disease will further increase uptake.

Jet nebulizers are expected to account for the second-largest share in the inhalation therapy nebulizer market over the forecast period due to the devices' low cost.

A jet nebulizer is a medical device that converts liquid medication into an aerosolized mist which is easy to inhale. Jet nebulizers are used to treat a range of pulmonary conditions, including asthma and cystic fibrosis. They are also known simply as nebulizers or atomizers. Many medical equipment suppliers sell these devices, along with accessories such as tubing, mouthpieces, and face masks which can be used with them.

A jet nebulizer is used when a patient might have difficulty taking medication in other ways, such as with a metered-dose inhaler. These devices are often used in hospital settings when a lot of medication needs to be delivered to the patient's lungs quickly, as when a patient is in respiratory distress. They can also be used at home for breathing treatments. Portable jet nebulizers are available for people with chronic pulmonary conditions who might require treatments while traveling. These factors are driving the growth of the market in the forecast period.

The hospital pharmacy is expected to dominate the inhalation therapy nebulizer market during the forecast period.

The hospital pharmacies held the largest share in the inhalation therapy nebulizer market. This is mainly owing to the increasing number of patients suffering from conditions that are treated in hospitals equipped with advanced infrastructure and adequate facilities. Moreover, the growing number of hospitals and adequate reimbursement policies are also contributing to the growth of this segment.

Geographical Analysis

North America region holds the largest market share global Inhalation Therapy Nebulizer market.

North America region is dominating the global inhalation therapy nebulizer market accounted for the largest market share in 2020. As the population in the region follows a fast-moving lifestyle, patients are looking for more portable nebulizer devices that can be transferred easily in a time of need for patients suffering from asthma and other airway diseases.

In addition, healthcare cost containment issues, post-economic crises in the United States have required the government to introduce new strategies to reduce patient stays in hospitals. This provided an impetus to homecare services, which created a favorable environment for the growth of the inhalation therapy nebulizer market.

Competitive Landscape

The inhalation therapy nebulizer market is moderately competitive with the presence of local as well as global companies.  Some of the key players which are contributing to the growth of the market include Rossmax International Ltd., OMRON Corporation, Koninklijke Philips N.V., PARI Pharma, BD, Medline Industries, Inc., Briggs Healthcare, GF Health Products, Inc., Vectura Group plc, Beurer GmBH among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which contribute to the growth of the inhalation therapy nebulizer market globally.   

Inhalation Therapy Nebulizer Market Key Companies to Watch 

 Beurer Gmbh

Overview: Beurer GmbH is located in Ulm, Baden-Württemberg, Germany and is part of the Medical Equipment & Supplies Manufacturing Industry. Beurer GmbH has 950 total employees across all of its locations and generates $312.73 million in sales (USD). There are 25 companies in the Beurer GmbH corporate family.

 Product Portfolio: Beurer GmbH manufactures blood sugar measuring units, blood pressure instruments, fever thermometers, electric blankets, bathroom and kitchen scales, footbaths and nebulizers, pulse watches, and other products.  

 

Trending Topics

Microsurgical Instruments Market

Automated Ophthalmic Perimeters Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest